News & Events about Summit Therapeutics Inc.
Stock Options Channel
1 year ago
Investors eyeing a purchase of Summit Therapeutics Inc (SMMT) stock, but cautious about paying the going market price of 2.52/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2025 ...
Summit Therapeutics Inc. (NASDAQ:SMMT Get Rating) CEO Mahkam Zanganeh bought 15,973,743 shares of the businesss stock in a transaction that occurred on Wednesday, March 8th. The stock was purchased at an average cost of $1.05 per share, with a total value of $16,772,430.15. Following ...
Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced the successful closing of its fully-subscribed $500 million rights offering. The rights offering resulted in the sale of approximately 476.2 million shares of the Companys common stock, par value $0.01, at a price...
PHILADELPHIA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit) on behalf of the Companys shareholders. The investigation seeks to determine whether Summit has issued false and misleading statements and/or failed to ...
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit) investors that the firm has initiated an investigation into whether Summit issued ...